Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Common Stock | Options Exercise | $0 | +6.17K | +2.08% | $0.00 | 302K | Jun 1, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Restricted Stock Units | Options Exercise | $0 | -6.17K | -100% | $0.00* | 0 | Jun 1, 2021 | Common Stock | 6.17K | Direct | F2, F3 | |
transaction | AXGN | Stock Option (right to buy) | Award | $0 | +6.03K | $0.00 | 6.03K | Jun 1, 2021 | Common Stock | 6.03K | $19.76 | Direct | F4 | |
transaction | AXGN | Restricted Stock Units | Award | $0 | +3.04K | $0.00 | 3.04K | Jun 1, 2021 | Common Stock | 3.04K | Direct | F2, F4 |
Id | Content |
---|---|
F1 | The shares of common stock for Dr. Gold include 159,575 shares held jointly by Dr. Gold and his wife, indirect ownership of 22,000 shares held by Dr. Gold's spouse in revocable trusts, and indirect ownership of 92,000 shares held by MJSK, Ltd., a decedent investment trust. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. |
F3 | This reflects the number of restricted stock units that became vested as of June 1, 2021. |
F4 | Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units. |